FORTIS · Healthcare · Medical Care Facilities
Composite scorecard: 58/100 — Quality 52 · Valuation 28 · Growth 72 · Momentum 100
| Share price | ₹951.20 |
| Market cap | ₹71,166 Cr |
| P/E ratio | 74.0 |
| P/B ratio | 7.6 |
| ROE | 54.9% |
| ROCE | 9.6% |
| Dividend yield | 0.11% |
| Book value | ₹124.78 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹9,128 Cr | ₹1,064 Cr | 23.0% |
| 2025 | ₹7,783 Cr | ₹809 Cr | 20.0% |
| 2024 | ₹6,893 Cr | ₹645 Cr | 18.0% |
| 2023 | ₹6,298 Cr | ₹633 Cr | 17.0% |
| 2022 | ₹5,718 Cr | ₹790 Cr | 19.0% |
Fortis Healthcare Limited operates as a healthcare delivery service provider in India. The company offers services in the areas of cardiac science, critical care, vascular surgery, dental science, dermatology, diabetology/endocrinology, emergency and trauma, geriatric medicine, liver transplant and hepatobiliary sciences, pain and palliative medicine, ENT, foetal medicine, gastroenterology and hepatology science, general surgery, and haematology areas. It also provides services in the areas of infertility medicine, internal medicine, mental health and behavioral science, nephrology, neuro surg